Register and share your invite link to earn from video plays and referrals.

Yoshitaka Moriwaki
@Ag_smith
とある文京区のラボォです。タンパク質の立体構造とバイオインフォマティクスに興味があります。I'm interested in protein bioinformatics. ORCID: 0000-0003-0448-9790
4.5K Following    12K Followers
🎉 Baker Lab just reported an exciting new advance in de novo enzyme design! 🧬 Using RFdiffusion3, the team built a site-selective ubiquitin ligase from scratch. On a PCNA trimer containing 45 competing lysines, it directed ubiquitin to K164 and achieved ~90% PCNA ubiquitination. This is a new wet-lab application of RFdiffusion3—not a recap of the model’s earlier release. The preprint shows that all-atom generative protein design can build a complex enzyme that controls not only whether ubiquitin is transferred, but where it goes. 🔬 A strong first experimental screen The team designed ligases around a cysteine-based catalytic triad. Of 48 designs tested, 35 transferred ubiquitin to a model peptide. 🎯 Selectivity on a difficult protein substrate PCNA is a homotrimer with many possible lysine acceptors. Rather than modifying the most accessible residue, the selected designs preferentially placed ubiquitin at K164—a key regulatory site in DNA-damage tolerance. ⚡ ~90% conversion with unactivated ubiquitin After adding an activity-enhancing mutation and coupling the system to E1 activation, the best design reached ~90% PCNA ubiquitination using unactivated ubiquitin. It also showed better site selectivity than the engineered E2 control. ⛓️ Programmable polyubiquitin installation The same cascade installed polyubiquitin chains of defined length onto K164 through native isopeptide bonds. That is a meaningful step beyond one-off protein labeling. 🧱 The designed fold was experimentally realized An apo crystal structure reached 1.6 Å resolution and closely matched the computational design, with a Cα RMSD of 0.91 Å. ⚠️ Important boundary: this is a bioRxiv preprint. The experiments use in-vitro activated donor chemistry or E1 + MESNa—not a demonstrated intracellular E1–E2–E3 ubiquitination pathway. The manuscript does not provide a verified official code repository or PDB accession. 📄 Preprint: #BakerLab# #RFdiffusion3# #ProteinDesign# #EnzymeDesign# #Ubiquitin# #AIforScience#
Show more
‼️ UPDATE: Microsoft's outage now reaches far beyond Outlook. Teams, SharePoint, Copilot and even its Defender XDR security platform are hit. Consumers can't reach their OneDrive storage or Office on the web either, TechCrunch reports. Microsoft first blamed elevated load. Now it says a large number of its servers became unexpectedly unavailable, dumping their load onto the rest. It hasn't said why. It is restarting the servers with a fix in place, investigating why they show high processor use, and has paused all deployments.
Show more
0
408
7.1K
2.2K
Forward to community
De novo design of orthogonal far-red, orange, and green fluorophore-binding proteins for multiplexed imaging
The Shinada (A03) group, in collaboration with Prof. Kuzuyama (A01) and Prof. Sato (A02) achieved the integrated chemoenzymatic synthesis of four dolabellane-type natural products using the diterpene cyclase, CotB2. @JOC_OL .
Show more
Warm thanks to everyone who took part in our conference held at Kitami Institute of Technology! Truly inspiring talks and discussions. Looking forward to the next conference in Tokyo this coming February!
Show more